Pharma
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Merck Statement in Response to the FDA's June 2009 Communication with Updated Information on Leukotriene Inhibitors, Including SINGULAIR (montelukast sodium)
Merck & Co., 06/15/09

Merck and Co., Inc. issued the following statement in response to communication from the U.S. Food and Drug Administration (FDA) addressing updated information on leukotriene inhibitors, including SINGULAIR (montelukast sodium).


Today in Research & Development...keeping you current

FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis
Abbott, 10/21/09

Dell Tries to Make an EHR Splash
HealthDataManagement, 11/03/09

Novel agent for treatment of Parkinson's disease - Lu 02-750 - enters Lundbeck's development pipeline
Lundbeck, 11/02/09

See All of Research & Development

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address